Doctor's Associates LLC v. Khononov

CourtDistrict Court, E.D. New York
DecidedFebruary 26, 2024
Docket1:22-cv-07637
StatusUnknown

This text of Doctor's Associates LLC v. Khononov (Doctor's Associates LLC v. Khononov) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Doctor's Associates LLC v. Khononov, (E.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

DOCTOR’S ASSOCIATES LLC and

SUBWAY® IP LLC, MEMORANDUM AND ORDER

Plaintiffs, Case No. 1:22-CV-7637-FB-RML

-against-

LYUDMILA KHONONOV,

Defendant.

Appearances: For the Defendant: For the Plaintiffs: MICHAEL A. TAMA JOHN DOROGHAZI Michael A. Tama, PC

Wiggin and Dana LLP 220 Old Country Road 265 Church Street Mineola, NY 11501

New Haven, CT 06510

BLOCK, Senior District Judge: Plaintiffs Doctor’s Associates LLP and Subway® IP LLC (collectively, “Plaintiffs”) move for (1) a stay of Defendant Lyudmila Khononov’s counterclaims for arbitration and (2) voluntary dismissal without prejudice of their claims pursuant to Federal Rule of Civil Procedure 41(a)(2). For the following reasons, Plaintiffs’ motion is granted. BACKGROUND Defendant operated a Subway franchise in Brooklyn, and after she closed her franchise and Plaintiffs terminated the franchise agreement, Defendant opened a new sandwich shop, “URWAY SUBS,” in the same location. Consequently, Plaintiffs commenced this action, alleging that Defendant violated their intellectual

property rights and the non-compete clause in the franchise agreement and moving for a preliminary injunction. On January 13, 2023, this Court denied Plaintiffs’ motion for a preliminary injunction because of failure to show irreparable harm.

See Doctor’s Assocs. LLC v. Khononov, No. 22-CV-7637 (FB), 2023 WL 184389 (E.D.N.Y. Jan. 13, 2023). Defendant counterclaimed for common-law fraud, intentional and negligent misrepresentation, unjust enrichment, and breach of contract relating to allegations that Subway’s tuna had no detectable tuna DNA

sequences. After their motion for injunctive relief failed, Plaintiffs sought to arbitrate their claims and Defendants’ counterclaims. The Franchise Agreement contains a

broad arbitration clause, stating, inter alia, “any dispute, controversy or claim arising out of or relating to this Agreement or the breach thereof shall be settled by arbitration.”1 By letter motion on November 30, 2023, Plaintiffs moved for voluntary

dismissal of their claims without prejudice and a stay of Defendant’s claims in

1 The Franchise Agreement’s arbitration provision contained a carve-out allowing Plaintiffs to bring an action for damages, injunctive relief, or both to enforce its “trademark or proprietary rights, the covenants not to compete, or the restriction on disclosure of Confidential Information.” favor of arbitration. Defendant failed to file any opposition by the Court-ordered opposition deadline, December 8, 2023. In a subsequent letter to the Court on

December 14, 2023, Plaintiffs’ counsel informed the Court that at a preliminary conference with the arbitrator that same day, Defendant’s counsel “did not disagree with Plaintiffs’ position that this entire matter should now proceed in arbitration.”

See ECF 45. DISCUSSION The Court first grants Plaintiffs’ motion to stay Defendant’s counterclaims in favor of arbitration. The Franchise Agreement’s arbitration provision covers

disputes “arising out of” the Agreement, and, as Defendant states in her Answer and Counterclaim, the action “arises out of a franchise agreement.” See ECF 20, at 3. Accordingly, because the arbitration provision covers the claims and is

enforceable, see, e.g., Doctor’s Assocs., Inc. v. Hamilton, 150 F.3d 157, 163 (2d Cir. 1998) (near-identical provision enforceable), the Federal Arbitration Act (“FAA”) requires a mandatory stay. See Katz v. Cellco P’ship, 794 F.3d 341, 346 (2d Cir. 2015).

Next, the Court grants Plaintiffs’ motion to voluntarily dismiss their claims without prejudice pursuant to Rule 41(a)(2). Under either of the two relevant tests under Rule 41(a)(2), voluntary dismissal is appropriate. See Camilli v. Grimes,

436 F.3d 120, 123 (2d Cir. 2006) (discussing “two lines of authority”). First, Plaintiffs have shown that Defendant would not suffer “plain legal prejudice other than the mere prospect of a second lawsuit.” Kwan v. Schlein, 634 F.3d 224, 230

(2d Cir. 2011). Second, Plaintiffs have also shown that the so-called Zagano factors warrant dismissal. See Camilli, 436 F.3d at 123 (citing Zagano v. Fordham University, 900 F.2d 12, 14 (2d Cir. 1990)). Specifically, Plaintiffs have shown

that: (1) they exercised diligence in bringing the motion, (2) there is no evidence of “vexatiousness” by the Plaintiffs, (3) the case has not progressed significantly outside the preliminary injunction decision, (4) there is little threat of duplicative expense of relitigation, and (5) Plaintiffs have proffered an adequate explanation

for their need to dismiss. Accordingly, the Court stays Defendant’s counterclaims and grants Plaintiffs’ motion to voluntarily dismiss their claims without prejudice pursuant to

Rule 41(a)(2). SO ORDERED. _/S/ Frederic Block___________ FREDERIC BLOCK Senior United States District Judge Brooklyn, New York February 26, 2024

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kwan v. Schlein
634 F.3d 224 (Second Circuit, 2011)
Doctor's Associates, Inc. v. Erik J. Hamilton
150 F.3d 157 (Second Circuit, 1998)
Katz v. Cellco Partnership
794 F.3d 341 (Second Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Doctor's Associates LLC v. Khononov, Counsel Stack Legal Research, https://law.counselstack.com/opinion/doctors-associates-llc-v-khononov-nyed-2024.